Express Pharma

Claims against Dr Reddy’s over Revlimid in US dismissed

On 22nd December, 2022 and 27th December, 2022, the plaintiffs voluntarily dismissed Dr Reddy’s Laboratories Limited and Dr Reddy’s Laboratories, Inc, respectively, from the case

1 150